Categories: News

Lyra Growth Partners Inc. Announces Sale of Common Shares of BuildDirect.com Technologies Inc.

Vancouver, British Columbia–(Newsfile Corp. – May 28, 2025) – Lyra Growth Partners Inc. (“Lyra“) announces that, on May 28, 2025, Lyra completed the private sale of an aggregate of 1,798,000 common shares (the “Common Shares“) of BuildDirect.com Technologies Inc. (“BuildDirect“) to four purchaser parties who are senior members of BuildDirect’s management team and its operating subsidiaries for a purchase price of Cdn$0.43 per Common Share and a total purchase price of Cdn$773,140 (the “Disposition“).

Immediately prior to the completion of the Disposition, Lyra owned a total of 8,686,557 Common Shares and 69,744 common share purchase warrants of BuildDirect (the “Warrants“).

Immediately following the completion of the Disposition, Lyra owns a total of 6,888,557 Common Shares, representing approximately 16.4% of the issued and outstanding Common Shares on a non-diluted basis, and assuming exercise in full of the Warrants, Lyra would own a total of 6,958,301 Common Shares, representing approximately 16.5% of the issued and outstanding Common Shares on a partially-diluted basis.

All of the securities held by Lyra in BuildDirect, including the Common Shares and the Warrants, are being held for investment purposes. Lyra may in the future take such actions in respect of its securityholdings in BuildDirect as it deems appropriate in light of the market circumstances then existing, including the potential purchase of additional shares of BuildDirect through open market purchases or privately negotiated transactions, a corporate transaction, such as a merger, reorganization or liquidation, involving BuildDirect, or the sale of all or a portion of such holdings in the open market or in privately negotiated transactions to one or more purchasers, or Lyra may continue to hold its current positions.

A copy of the early warning report relating to the Common Shares will be available under BuildDirect’s profile on SEDAR+ at www.sedarplus.ca, and may also be obtained by contacting Lyra Growth Partners Inc. at 604-354-3327. Lyra’s head office is located at 2150 – 1055 West Hastings Street, Vancouver, British Columbia, V6E 2E9, Canada.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/253772

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

2 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

2 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago